Opioid growth factor (OGF/met-enkephalin) inhibited human pancreatic, colon, and squamous cell cancer proliferation through a novel nuclear receptor (OGFr) activating p16 and p21 cell cycle inhibitors — a distinct anti-cancer opioid mechanism.
Built-in tumor suppressionMet-enkephalin activates p16/p21 tumor suppressors through a nuclear receptor — the body has its own opioid-based cancer control system
What the researchers found
Met-enkephalin (OGF) inhibited cancer proliferation through OGFr nuclear translocation and activation of p16/p21 cell cycle inhibitors across pancreatic, colon, and squamous cell cancers — a non-classical opioid anti-cancer mechanism.
Why it matters
A natural opioid peptide that suppresses cancer through tumor suppressor activation represents an entirely new anti-cancer mechanism. It could be boosted to enhance natural tumor control.
How the study worked
In-vitro study using three human cancer cell lines. OGF binding, OGFr localization, p16/p21 induction, and cell cycle arrest measured. Classical opioid receptor involvement excluded with selective antagonists.
What this study cannot tell us
In-vitro cancer cell lines. The OGFr pathway's in-vivo significance and therapeutic potential need validation.
How to read the evidence
Preliminary in-vitro evidence across three cancer types with clear non-classical receptor identification and tumor suppressor activation.
When this study was published
Published in 2003. The OGF-OGFr pathway has been further characterized and is being explored for cancer therapy.
The bigger picture
The body has a built-in opioid-based tumor suppression system. Met-enkephalin naturally slows cancer growth through OGFr — boosting this system could be a novel cancer treatment strategy.
Questions still open
- Could OGFr agonists be developed as cancer drugs?
- Is the OGF-OGFr pathway deficient in cancer patients?
- Would opioid drugs that block classical receptors inadvertently affect this anti-cancer pathway?
Common questions
Can the body's opioids fight cancer?
Could this be used for cancer treatment?
Read the original research
Opioids and the apoptotic pathway in human cancer cells.
Neuropeptides, 37(2), 79-88
Citation
Zagon, Ian S; McLaughlin, Patricia J. (2003). Opioids and the apoptotic pathway in human cancer cells.. Neuropeptides, 37(2), 79-88.